Phase 2a randomized study to evaluate sapablursen in patients with non-transfusion dependent β-thalassemia intermedia.
- DOI
- 10.1182/bloodadvances.2026019799
- Published
- 2026 Jun 4
- Container
- Blood advances
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1182/bloodadvances.2026019799,
title = {Phase 2a randomized study to evaluate sapablursen in patients with non-transfusion dependent β-thalassemia intermedia.},
author = {Taher A and Diamantidis MD and Kattamis A and Aydinok Y and Kaplan ZS and Dibble A and Dorow S and Doherty S and Mathews J and Jung S and Goldberg YP and Tami J and Bhanot S and Schneider E and Monia BP and Barrett TD},
year = {2026},
journal = {Blood advances},
doi = {10.1182/bloodadvances.2026019799},
url = {https://doi.org/10.1182/bloodadvances.2026019799}
}RIS
TY - JOUR TI - Phase 2a randomized study to evaluate sapablursen in patients with non-transfusion dependent β-thalassemia intermedia. AU - Taher A AU - Diamantidis MD AU - Kattamis A AU - Aydinok Y AU - Kaplan ZS AU - Dibble A AU - Dorow S AU - Doherty S AU - Mathews J AU - Jung S AU - Goldberg YP AU - Tami J AU - Bhanot S AU - Schneider E AU - Monia BP AU - Barrett TD PY - 2026 JO - Blood advances DO - 10.1182/bloodadvances.2026019799 UR - https://doi.org/10.1182/bloodadvances.2026019799 ER -
APA
A, T., MD, D., A, K., Y, A., ZS, K., A, D., S, D., S, D., J, M., S, J., YP, G., J, T., S, B., E, S., BP, M., & TD, B. (2026). Phase 2a randomized study to evaluate sapablursen in patients with non-transfusion dependent β-thalassemia intermedia.. Blood advances. https://doi.org/10.1182/bloodadvances.2026019799
Source records
- pubmed · retrieved 2026-09-26T05:29:35.976Z